Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in childrenRobert S. B. Clark, Michael J. Bell, Philip E. Empey et al.|PLoS ONE|2017Cited by 56
Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh VisionPatrick M. Kochanek, C. Edward Dixon, Robert S. B. Clark et al.|Journal of Neurotrauma|2018Cited by 54
ABCB1 genotype is associated with fentanyl requirements in critically ill childrenChristopher M. Horvat, Robert S. B. Clark, Alicia K. Au et al.|Pediatric Research|2017Cited by 26
Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill ChildrenFanuel T. Hagos, Philip E. Empey, Christopher M. Horvat et al.|Clinical Pharmacokinetics|2019Cited by 13
Membrane transporters in traumatic brain injury: Pathological, pharmacotherapeutic, and developmental implicationsFanuel T. Hagos, Philip E. Empey, Solomon M. Adams et al.|Experimental Neurology|2019Cited by 8